Effingham, IL—May 18, 2017
Bonutti Research Inc. and Zimmer Biomet have entered into a license agreement for Zimmer Biomet’s use of two patent families created by Dr. Peter Bonutti. U.S. Patent No. 9,301,845 adds to the strength of the innovative knee systems, Persona® The Personalized Knee System and the NexGen® Complete Knee Solution. U.S. Patent Nos. 9,629,687 and 9,585,725 support the development of the Rosa® robotic total knee application currently underway at Zimmer Biomet. With intellectual properly licensed from Bonutti Research, Zimmer Biomet is in a stronger position to develop and deploy safe, effective and innovative products for the marketplace.
About Bonutti Research (BRI)
Founded by Peter Bonutti, MD in 1989, BRI is a medical device incubator with over 550 patents and patent applications involving diagnostics, surgical robotics, minimal invasive surgery, soft tissue fixation, and hip and knee arthroplasty. BRI has entered into over 740 licenses in numerous medical and surgical fields. With in-house design, engineering, regulatory, manufacturing and intellectual property capabilities, Bonutti Research is a true device incubator and full service partner. Learn more about innovations from BRI at bonuttiresearch.com